Keros Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for disorders linked to dysfunctional signaling of the TGF-ß family of proteins. The company serves patients with conditions such as pulmonary arterial hypertension, neuromuscular diseases, and blood-related disorders.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.